Clinical Trials Directory

Trials / Completed

CompletedNCT01814020

An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
—
Sponsor
Moberg Pharma AB · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
—

Summary

Assess efficacy and safety of topical MOB015B, applied daily during 48 weeks, in adults with fungal nail infection.

Conditions

Interventions

TypeNameDescription
DRUGMOB015B

Timeline

Start date
2012-12-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2013-03-19
Last updated
2014-09-22

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01814020. Inclusion in this directory is not an endorsement.

An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychom (NCT01814020) · Clinical Trials Directory